Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × Idarubicin × Clear all

NCT05280444 2022-12-29

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular